期刊文献+

PRDM16基因单核苷酸多态性与肥胖人群血脂异常的相关性 被引量:7

Polymorphism of PRDM16 gene:effect on dyslipidemia in obese patients
原文传递
导出
摘要 目的:探讨PRDM16基因与新疆维吾尔族肥胖患者血脂异常的关系。方法:采用毛细管电泳法对36例BMI≥30kg/m2个体进行PRDM16启动子区及外显子区测序,筛查该基因功能区的变异位点。选择有代表性变异位点,在533例新疆维吾尔族肥胖人群中进行基因型鉴定。采用病例对照的方法分析PRDM16基因变异与该人群的血脂异常之间的关系。结果:在PRDM16基因的功能区发现21个变异位点,其中rs2236518、rs2493292、rs2282198和rs8170171位点成功进行了基因型鉴定。rs2282198的基因型频率在高胆固醇血症组和对照组(P=0.04)及低高密度脂蛋白胆固醇组和对照组(P=0.006)之间分布差异有统计学意义。rs2236518的基因型频率在低高密度脂蛋白胆固醇组和对照组之间分布差异有统计学意义(P=0.015)。校正混杂因素后Logistic回归分析显示,rs2282198的CT+TT基因型是高三酰甘油血症(OR:1.789,95%CI:1.159~2.762,P=0.008)及低高密度脂蛋白胆固醇血症(OR:0.539,95%CI:0.350~0.830,P=0.005)的独立危险因素。数量表型分析显示,校正混杂因素后,rs2282198的CT+TT基因型携带者血清HDL-C显著低于CC携带者(P=0.021)。结论:PRDM16基因的变异位点rs2282198与新疆维吾尔族肥胖者的血脂异常相关。 Objective:To analyze the association between the genetic variations of functional region in PRDM16 gene and dyslipidemia in Uygur obese subjects. Method: We screened the promoter and all exons of the PRDM16 gene in 36 Uygur obese individuals to identify representative variations. Genotyping was performed in 533 Uygur obese individuals. A case-control study was conducted to test the association between variants of PRDM16 and dyslipidemia. Result:Twenty-two variants were identified and 4 SNPs were genotyped. The SNP, rs2282198 has significantly different genotype frequencies between case and control subjects (P= 0.04 for hypercholesterolemia) and (P=0. 006 for low HDL-C). The significance was also observed for rs2236518 between hypercholesterolemia and control groups (P =0. 015). Logistic regression tests showed the CTTTT genotypes of rs2282198 was the independent risk factor of hypercholesterolemia (OR: 1. 789, 95%CI= 1. 159--2. 762, P=0. 008) and low HDL C (OR: 0.539, 95%CI: 0.350--0.830, P=0.005). The quantitative trait analyses showed the effect ofrs2282198 on serum HDL-C (P=0. 021 after adjustment for confound factors). Conelusion: In the obese people, variant in PRDM16 gene may have some effect on lipid metabolism and cause variation in serum lipid concentrations.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第9期657-661,共5页 Journal of Clinical Cardiology
基金 新疆维吾尔自治区高科技研究与发展平台项目(No:201010107)
关键词 棕色脂肪 测序 血脂异常 肥胖 单核苷酸多态性 brown fat sequence dyslipidemia obesity single nucleotide polymorphism
  • 相关文献

参考文献14

  • 1VIRTANEN K A, LIDEI.I. M E, ORAVA J, et al. Functional brown adipose tissue in healthy aduhs[J]. N EnglJ Med,2009,360:1518 1525.
  • 2CYPESS A M, LEHMAN S, WILLIAMS C-, et al. Identification and importance of brown adipose tissue inaduh humans[J]. N EnglJ Med,2009,360:1509 1517.
  • 3FRANCESCO S C. Brown adipose tissue-when it pays to beinefficient[J]. N Engl J Med,2009,360:1553 1556.
  • 4SEALE P, KAJIMURA S, YANG W, et al. Tran- scriptional control of brown fat determination by PRDM1f[J]. Cell Metab,2007,6:38-54.
  • 5YONG-MOON P, MICHAEL A P, GAO X Y, et al. Longitudinal trends in the association of metabolic syndrome with 550 k single nueleotide polymorphisms in the Framingbam Hearl Study[J]. BMC Proceed- ings,2009,3(Suppl 7)$116- 116.
  • 6ZHANC- J H, LI N F, YAN Z T, et al. Association of genetic variations of PRDM16 with metabolic syn drome in a general Xinjiang Uygur population[J]. En docrine, 2012,41 : 539 - 541.
  • 7COHEN J C, KISS R S, PERTSEMLIDIS A, et al. Multiple rare alleles contribute to low plasma levels of HI)L cholesterol[J]. Science, 2004,305,869 - 872.
  • 8HEI.LER D A, DE FAIRE U, PEDERSEN N L, et al. Genetic and environmental influences on serum lipid levels intwins[J]. NEnglJ Med,1993,328:1150 1156.
  • 9王虹剑,李卫菊,王虎,傅春燕,孙凯,石毅,杨旭,甄一松,宋晓东,杨晓敏,惠汝太.核糖体蛋白S6激酶1基因C19012T多态性与农村超重人群血脂水平相关[J].临床心血管病杂志,2007,23(6):468-471. 被引量:2
  • 10WANG L F, TAO Y C, XIE Z J, et al. Prevalence of metabolic syndrome, insulin resistance, impaired fasting blood glucose, and dyslipidemia in Uygur and Ka zak populations[J]. J Clin Hyperlens (Greenwich), 2010,12:741-745.

二级参考文献56

  • 1付剑江,陈晓光.TOR(target of rapamycin)介导的翻译调控[J].哈尔滨商业大学学报(自然科学版),2005,21(4):399-404. 被引量:5
  • 2FINGAR D C,BLENIS J.Target of rapamycin (TOR):an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression[J].Oncogene,2004,23:3151-3171.
  • 3DENNIS P B,JAESCHKE A,SAITOH M.et al.Mammalian TOR:a homeostatic ATP sensor[J].Science,2001,294:1102-1105.
  • 4UM S H,FRIGERIO F,WATANABE M,et al.Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity[J].Nature,2004,431:200-205.
  • 5LEADON S A,CERUTTI P A.A rapid and mild procedure for the isolation of DNA from mammalian cells[J].Anal Biochem,1982,120:282-8.
  • 6SALTIEL A R,KAHN C R.Insulin signalling and the regulation of glucose and lipid metabolism[J].Nature,2001,414:799-806.
  • 7FINGAR D C,SALAMA S,TSOU C,et al.Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E[J].Genes Dev,2002,16:1472-1487.
  • 8UM S H,D'ALESSIO D,THOMAS G.Nutrient overload,insulin resistance,and ribosomal protein S6 kinase 1,S6K1[J].Cell Metab,2006,3:393-402.
  • 9MOOTHA V K,LINDGREN C M,ERIKSSON K F,et al.PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes[J].Nat Genet,2003,34:267-273.
  • 10PATTI M E,BUTTE A J,CRUNKHORN S,et al.Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:Potential role of PGC1 and NRF1[J].Proc Natl Acad Sci U S A,2003,100:8466-8471.

共引文献37

同被引文献42

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部